article
12 September 2016 | By Debra Taylor (MRC Technology), Emilie Bureau (MRC Technology), Janet Brownlees (MRC Technology)
Over the past few years several factors in the drug discovery industry have come together to drive an increased interest and subsequent surge in the use of high-content imaging. These include the high costs of attrition in the clinic due to lack of efficacy; increased hurdles and rising costs to…